AU2009309277A8 - Efficient expression of truncated human RNASET2 in E. Coli - Google Patents

Efficient expression of truncated human RNASET2 in E. Coli

Info

Publication number
AU2009309277A8
AU2009309277A8 AU2009309277A AU2009309277A AU2009309277A8 AU 2009309277 A8 AU2009309277 A8 AU 2009309277A8 AU 2009309277 A AU2009309277 A AU 2009309277A AU 2009309277 A AU2009309277 A AU 2009309277A AU 2009309277 A8 AU2009309277 A8 AU 2009309277A8
Authority
AU
Australia
Prior art keywords
coli
efficient expression
truncated human
human rnaset2
rnaset2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009309277A
Other versions
AU2009309277A1 (en
Inventor
Liron Nuttman
Levava Roiz
Betty Schwartz
Oded Shoseyov
Patricia Smirnoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Publication of AU2009309277A1 publication Critical patent/AU2009309277A1/en
Publication of AU2009309277A8 publication Critical patent/AU2009309277A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2009309277A 2008-10-30 2009-10-29 Efficient expression of truncated human RNASET2 in E. Coli Abandoned AU2009309277A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19313408P 2008-10-30 2008-10-30
US61/193,134 2008-10-30
PCT/IL2009/001012 WO2010049933A1 (en) 2008-10-30 2009-10-29 Efficient expression of truncated human rnaset2 in e. coli

Publications (2)

Publication Number Publication Date
AU2009309277A1 AU2009309277A1 (en) 2010-05-06
AU2009309277A8 true AU2009309277A8 (en) 2011-05-12

Family

ID=41694413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009309277A Abandoned AU2009309277A1 (en) 2008-10-30 2009-10-29 Efficient expression of truncated human RNASET2 in E. Coli

Country Status (8)

Country Link
US (1) US20110207667A1 (en)
EP (1) EP2346993A1 (en)
JP (1) JP2012507278A (en)
AU (1) AU2009309277A1 (en)
CA (1) CA2739705A1 (en)
EA (1) EA201100610A1 (en)
WO (1) WO2010049933A1 (en)
ZA (1) ZA201102615B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2014138583A (en) * 2012-02-29 2016-04-20 Ф. Хоффманн-Ля Рош Аг METHOD FOR REDUCING 1- SHIFT OF THE READING FRAME
EP3004339B1 (en) * 2013-05-29 2021-07-07 Cellectis New compact scaffold of cas9 in the type ii crispr system
US20160340659A1 (en) 2014-01-30 2016-11-24 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
CN109462996A (en) * 2016-03-17 2019-03-12 西达-赛奈医疗中心 The method for diagnosing inflammatory bowel disease by RNASET2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60044977D1 (en) * 1999-09-24 2010-10-28 Ambion Inc COCKTAIL OF NUCLEASE INHIBITORS
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
ES2524601T3 (en) * 2004-09-29 2014-12-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Recombinant human T2 RNase and uses thereof
US7608413B1 (en) * 2005-03-25 2009-10-27 Celera Corporation Kidney disease targets and uses thereof

Also Published As

Publication number Publication date
JP2012507278A (en) 2012-03-29
CA2739705A1 (en) 2010-05-06
AU2009309277A1 (en) 2010-05-06
ZA201102615B (en) 2012-03-28
US20110207667A1 (en) 2011-08-25
WO2010049933A1 (en) 2010-05-06
EP2346993A1 (en) 2011-07-27
EA201100610A1 (en) 2011-10-31

Similar Documents

Publication Publication Date Title
PL2376537T3 (en) Human antibodies against human tissue factor.
EP2293705B8 (en) Chair
EP2349990B8 (en) Aryl-phenyl-sulfonamide-phenylene compounds and their use
AU2009309277A8 (en) Efficient expression of truncated human RNASET2 in E. Coli
IL212588A0 (en) Efficient expression of truncated human rnaset2 in e. coli
AU2008100685A4 (en) Medical Lines Stay
AU2007902996A0 (en) Human powered systems - HPS
AU2008906349A0 (en) Compoundsfor medical application
AU2008903020A0 (en) Treatment
AU2008900432A0 (en) Tissue specific expression
AU2008904644A0 (en) Health chair
AU2008902821A0 (en) Titanium based microbelts
AU2008902139A0 (en) HLST Therapy
AU2008905233A0 (en) Catapillar back massager
AU2008903284A0 (en) Combination therapy
AU2008902835A0 (en) Tribal - a skin care range
AU2008903406A0 (en) Imidazopyrimidinones and uses thereof
AU2008903405A0 (en) Thiazopyrimidinones and uses thereof
AU2008902850A0 (en) Chair
AU2009100840A4 (en) Proctective Skin
AU2008905626A0 (en) Water treatment
AU2008904490A0 (en) Water Treatment
AU2009900539A0 (en) Bacteriophage therapy in livestock
AU2008903394A0 (en) Pain-relieving compositions and uses therefor
AU2008904197A0 (en) Pain-relieving compositions and uses therefor

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 25, NO 17, PAGE(S) 2088 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD., APPLICATION NO. 2009309277, UNDER INID (54) CORRECT THE TITLE TO EFFICIENT EXPRESSION OF TRUNCATED HUMAN RNASET2 IN E. COLI

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application